[Management of childhood pseudocroup with budesonide inhalation].
The authors examined 85 children who had serious recurrent pseudogroup syndrome, and re-examined them 1-3 years later. 1/3 of the patients was also allergic, mostly to mites and grasspollens. The patients got either regular, daily two inhalation, or their parents were taught to inspire the drug in the case of stenotic cough of hoarseness. Half of the patients did not answer to our letter. The parents of 43 patients answered and described their observations according to the inquiry letter. 2/3 of treated children either amolioreted definitely of became symptom free. 12 patients had 30 laryngeal attacks before the budesonide treatment whereas only 3 attacks, needing hospitalisation, occurred after the budesonide treatment. 6 patients experienced definite amelioration and two children's state worsened. Budesonide therapy seemed to be useful in the prevention and therapy of recurrent laryngitic children. Further experiences using turbo-inhaler and placebo would be important for more definite statement. Nevertheless inhalative budesonide is the first drug promising fast remission of laryngeal edema.
Osváth
P
P
IX. Allergológia és Pulmonológia Osztály, Szabadsághegyi Gyermekgyógyintézet, Budapest.
Kelenhegyi
K
K
Szánthó
A
A
D001993:Bronchodilator Agents / Q000008:administration & dosage; D019819:Budesonide; D002648:Child; D003371:Cough / Q000188:drug therapy / Q000209:etiology; D003440:Croup / Q000175:diagnosis / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007827:Laryngitis / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D011282:Pregnenediones / Q000008:administration & dosage*; D012008:Recurrence; D012138:Respiratory Therapy
D001993:Bronchodilator Agents; D011282:Pregnenediones; D019819:Budesonide
Gyermekkori pseudocroup kezelése inhalativ budesoniddal.